Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00365482 · ClinicalTrials.gov registry record
Bipolar Disorder in Epilepsy
A clinical trial of Epilepsy and Bipolar Disorder, sponsored by Northwell Health.
- Completed
- Registry status
- 102
- Enrollment target
- 1
- Study location
NCT00365482: Completed study of Epilepsy and Bipolar Disorder, sponsored by Northwell Health.
NCT00365482 is a study of Epilepsy and Bipolar Disorder that has completed, run by Northwell Health. The registered enrollment target is 102 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00365482, a study of Epilepsy and Bipolar Disorder, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out how often major mood swings occur in patients treated in a specialty epilepsy center.
Conditions Studied
Study Locations (1)
New York
- North Shore Long Island Jewish Health System - Great Neck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2006-08 |
| Est. Completion | 2011-12 |
What the finished NCT00365482 record still lists
NCT00365482 is an observational study that tracks outcomes without assigning an intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 0 interventions.
NCT00365482 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00365482 about?
NCT00365482 is a clinical study titled "Bipolar Disorder in Epilepsy". The purpose of this study is to find out how often major mood swings occur in patients treated in a specialty epilepsy center.
What is the current status of trial NCT00365482?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2006-08. Estimated completion is 2011-12.
What conditions does trial NCT00365482 study?
This clinical trial studies the following conditions: Epilepsy, Bipolar Disorder.
Who is sponsoring clinical trial NCT00365482?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00365482 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00365482's enrollment target sits among peer trials
102 53rd of 160 higher than 108 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia